We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A trial of integrated buprenorphine/naloxone and HIV clinical care.
- Authors
Sullivan, Lynn E; Barry, Declan; Moore, Brent A; Chawarski, Marek C; Tetrault, Jeanette M; Pantalon, Michael V; O'Connor, Patrick G; Schottenfeld, Richard S; Fiellin, David A
- Abstract
Untreated opioid dependence adversely affects the care of human immunodeficiency virus (HIV)-positive patients. Buprenorphine, a partial opioid agonist, is available for maintenance treatment of opioid dependence in HIV specialty settings. We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Vol 43 Suppl 4, pS184
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/508182